News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Annual Shareholders' Meeting of InNexus Biotechnology Inc. (IXS): Shareholders Approve All Resolutions



5/26/2011 12:04:42 PM

InNexus Biotechnology Inc. (TSX:IXS.V), a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, announces that its shareholders have approved all resolutions at the Annual Shareholders Meeting of May 24, 2011. The following resolutions were approved:

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES